首页> 外国专利> TISSUE-SPECIFIC HUMAN BIOINKS FOR THE PHYSIOLOGICAL 3D-BIOPRINTING OF HUMAN TISSUES FOR IN VITRO CULTURE AND TRANSPLANTATION

TISSUE-SPECIFIC HUMAN BIOINKS FOR THE PHYSIOLOGICAL 3D-BIOPRINTING OF HUMAN TISSUES FOR IN VITRO CULTURE AND TRANSPLANTATION

机译:组织特定的人类生物墨水,用于人体组织的3D生物学体外培养和移植

摘要

The present invention relies on the discovery that the combination of two biomaterials, human tissue-specific ECM (extracellular matrix)and a cellulose-based bioink, with or without cells, in the 3Dbioprinting of human tissues and scaffolds, results in excellent printability and improved cell function, viability and engraftment. The present invention is based on the first report describing the bioprinting of human tissue, specifically hepatic tissue,using human ECM, specifically liver ECM,in combination with cellulose-based bioink. More specifically, the present invention refers to a composition for use in 3Dbioprinting and culturing of human or animal tissue comprising(i)cellulose nanofibril-based bioink, and(ii) human or animal tissue-specific extracellular matrix (ECM) material. Further, the invention relates to a method for 3Dbioprinting of human tissue and /or scaffolds comprising bioprinting the composition of the invention, as well as the bioprinted tissues and/or scaffolds. Moreover, the invention relates to various applications using the bioprinted tissues and/or scaffolds.
机译:本发明依赖于以下发现:在人体组织和支架的3D生物打印中,两种生物材料的组合,即人体组织特异性ECM(细胞外基质)和基于纤维素的生物墨水(带有或不带有细胞)的结合,可导致出色的可印刷性并得到改善细胞功能,生存力和植入。本发明基于第一份报告,其描述了使用人ECM,特别是肝ECM,结合基于纤维素的生物墨水,对人组织,特别是肝组织进行生物打印。更具体地,本发明涉及用于人或动物组织的3D生物打印和培养的组合物,其包含(i)纤维素纳米原纤维基生物墨水和(ii)人或动物组织特异性细胞外基质(ECM)材料。此外,本发明涉及用于人体组织和/或支架的3D生物打印的方法,其包括对本发明的组合物以及生物打印的组织和/或支架进行生物打印。此外,本发明涉及使用生物打印的组织和/或支架的各种应用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号